W81XWH-21-1-0163/selective metabolic dependencies in kidney cancer with mitochondrial mutations

Ended Project Grant Awarded Last action

Award ID
W81XWH2110163
Recipient
Awarding agency
Obligated
$166,726

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Boston, MA 02115, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Dana-Farber Cancer Institute, Inc. was awarded a $166,726 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The two-year grant will support Selective Metabolic Dependencies in Kidney Cancer with Mitochondrial Mutations research from April 2021 through April 2023.

The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will investigate metabolic dependencies in kidney cancer cells containing mitochondrial mutations, advancing the program's goal to develop medical solutions applicable to service members and the general public. The research findings could help identify new treatment targets and approaches for kidney cancer patients.

Transactions

Action Obligated Date
Amendment The purpose of this modification is to extend the period of performance by 12 months at no additional cost to the government, per the recipient is request dated… $0
Original award $166,726

Quick answers

Who received award W81XWH2110163?

W81XWH2110163 was awarded to Dana-Farber Cancer Institute, Inc. by Medical Command (Department of the Army) on April 15, 2021.

How much is award W81XWH2110163 worth?

$166,726 has been obligated on W81XWH2110163.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login